Home › Funds › Propel Bio Management, LLC › UPB

Propel Bio Management, LLC position in UPB

UPSTREAM BIO INC · Health Care

Propel Bio Management, LLC reported holding 335,389 shares of UPB (UPSTREAM BIO INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.94% of its reported portfolio and ranking #26 among its reported holdings. Propel Bio Management, LLC has disclosed UPB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)335.39K sh
Reported value held$1.77M
Portfolio Weight0.94%
First reportedQ1 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Propel Bio Management, LLC's UPB position evolved

Propel Bio Management, LLC first disclosed a stake in UPB in Q1 2026 at 341,779 shares (US$3.1M). Across 3 filings, Propel Bio Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 335,389 shares valued at US$1.8M — a reduction of -15,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 341.78K $3.10M New
Q2 2026 350.39K $2.42M Add
Q3 2026 335.39K $1.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About UPB and 13F data

UPB (UPSTREAM BIO INC) is a Health Care company. 50 other funds we track also report a position in UPB — the largest reported positions include ORBIMED ADVISORS LLC (US$39.4M), Decheng Capital LLC (US$18.9M), Enavate Sciences GP, LLC (US$17.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding UPB

All UPB fund holders →

FAQ

How long has Propel Bio Management, LLC held UPB?

Propel Bio Management, LLC has disclosed UPB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Propel Bio Management, LLC's current position in UPB?

As of Q3 2026, Propel Bio Management, LLC holds 335.39K shares of UPB (UPSTREAM BIO INC), valued at $1.77M, representing 0.94% of its reported portfolio and ranking #26.

Has Propel Bio Management, LLC been buying or selling UPB?

In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in UPB.

Which other funds hold UPB?

Other major institutional holders of UPB include ORBIMED ADVISORS LLC, Decheng Capital LLC, Enavate Sciences GP, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.